{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:30Z","timestamp":1761513330364},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ejso.2013.07.087","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T06:15:46Z","timestamp":1375769746000},"page":"1122-1128","source":"Crossref","is-referenced-by-count":18,"title":["Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI\u00ae) for colorectal liver metastases does not predict tumour destruction or long-term outcome"],"prefix":"10.1016","volume":"39","author":[{"given":"R.P.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"St\u00e4ttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.F.J.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Smethurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Terlizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Z.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.","family":"Poston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejso.2013.07.087_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2013.07.087_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdl386","article-title":"Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery","volume":"18","author":"Rubbia-Brandt","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2013.07.087_bib3","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2335-1","article-title":"Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome","author":"Poultsides","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2013.07.087_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/SLA.0b013e31815aa2c2","article-title":"Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients","volume":"247","author":"Rees","year":"2008","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2013.07.087_bib5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-010-1288-5","article-title":"Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study","volume":"18","author":"Martin","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2013.07.087_bib6","volume":"6","author":"Jones","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2013.07.087_bib7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejso.2013.07.087_bib8","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1001\/jama.2009.1755","article-title":"Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases","volume":"302","author":"Chun","year":"2009","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejso.2013.07.087_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"33","key":"10.1016\/j.ejso.2013.07.087_bib10","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2013.07.087_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/SLA.0b013e31822f4f88","article-title":"Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer","volume":"254","author":"House","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2013.07.087_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","article-title":"Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases","volume":"201","author":"Allen","year":"2005","journal-title":"J\u00a0Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ejso.2013.07.087_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","article-title":"Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases","volume":"230","author":"Fong","year":"1999","journal-title":"Ann Surg"},{"issue":"24","key":"10.1016\/j.ejso.2013.07.087_bib14","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2006.05.8727","article-title":"Complete response of colorectal liver metastases after chemotherapy: does it mean cure?","volume":"24","author":"Benoist","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2013.07.087_bib15","article-title":"Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience","author":"Martin","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2013.07.087_bib16","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.ejso.2013.07.087_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/cncr.23184","article-title":"Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study","volume":"112","author":"Ng","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2013.07.087_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","article-title":"Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial","volume":"11","author":"Folprecht","year":"2010","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2013.07.087_bib19","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/sj.bjc.6605940","article-title":"Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial","volume":"103","author":"Garufi","year":"2010","journal-title":"Br J Cancer"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313005490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798313005490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T04:23:11Z","timestamp":1539490991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798313005490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0748798313005490"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2013.07.087","relation":{},"ISSN":["0748-7983"],"issn-type":[{"type":"print","value":"0748-7983"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}